OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
INAM56

Indo Amines Ltd

Diversified ChemicalsVerified

Indo Amines has a debt-to-equity ratio of 0.9 and a current ratio of 1.26, indicating moderate liquidity and a balanced capital structure. However, the company reported negative net cash after subtracting total debt, signaling potential liquidity constraints. Free cash flow is negative at -137.8 million INR, driven by capital expenditures of -831.8 million INR, suggesting ongoing investment in operations. Profitability metrics show a return on equity of 17.43% and a return on assets of 7.09%, which are strong relative to the industry median for Diversified Chemicals. The company’s operating margin is 7.85% (calculated as operating income of 846.8 million INR divided by revenue of 10,786.8 million INR), and its net margin is 5.12% (net income of 552.5 million INR over revenue of 10,786.8 million INR). These figures suggest efficient cost management and competitive returns. The company’s revenue is concentrated in India, with no disclosed international revenue segments. Its product portfolio spans fine, specialty, and performance chemicals, with no single segment accounting for more than 50% of total revenue. This diversification reduces exposure to any one market or product line. Looking ahead, Indo Amines is expected to maintain stable revenue growth, supported by demand in pharmaceuticals and road construction. The company’s capital expenditures suggest a focus on maintaining and expanding production capacity. Risk factors include moderate liquidity risk due to negative net cash and a high debt load. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. Recent filings and transcripts have not disclosed any material events that would significantly alter the company’s financial trajectory. The company remains focused on operational efficiency and product diversification.

30-day price · INAM+32.96 (+37.5%)
Low$83.01High$125.80Close$120.80As of12 May, 00:00 UTC
Profile
CompanyIndo Amines Ltd
TickerINAM.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Indo Amines Limited is a chemical manufacturing company that produces fine, specialty, and performance chemicals for use in pharmaceuticals, petrochemicals, road construction, and other industries.

Classification. Indo Amines is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

Indo Amines has a debt-to-equity ratio of 0.9 and a current ratio of 1.26, indicating moderate liquidity and a balanced capital structure. However, the company reported negative net cash after subtracting total debt, signaling potential liquidity constraints. Free cash flow is negative at -137.8 million INR, driven by capital expenditures of -831.8 million INR, suggesting ongoing investment in operations. Profitability metrics show a return on equity of 17.43% and a return on assets of 7.09%, which are strong relative to the industry median for Diversified Chemicals. The company’s operating margin is 7.85% (calculated as operating income of 846.8 million INR divided by revenue of 10,786.8 million INR), and its net margin is 5.12% (net income of 552.5 million INR over revenue of 10,786.8 million INR). These figures suggest efficient cost management and competitive returns. The company’s revenue is concentrated in India, with no disclosed international revenue segments. Its product portfolio spans fine, specialty, and performance chemicals, with no single segment accounting for more than 50% of total revenue. This diversification reduces exposure to any one market or product line. Looking ahead, Indo Amines is expected to maintain stable revenue growth, supported by demand in pharmaceuticals and road construction. The company’s capital expenditures suggest a focus on maintaining and expanding production capacity. Risk factors include moderate liquidity risk due to negative net cash and a high debt load. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. Recent filings and transcripts have not disclosed any material events that would significantly alter the company’s financial trajectory. The company remains focused on operational efficiency and product diversification.
Key takeaways
  • Indo Amines maintains a strong return on equity (17.43%) and return on assets (7.09%), indicating efficient capital use.
  • The company’s debt-to-equity ratio of 0.9 and current ratio of 1.26 suggest a balanced capital structure with moderate liquidity risk.
  • Free cash flow is negative due to high capital expenditures, signaling ongoing investment in operations.
  • Revenue is concentrated in India, with no disclosed international exposure, limiting diversification benefits.
  • Dilution risk is low, with no near-term pressure from share issuance or convertible debt.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$10.79B
Gross profit$2.82B
Operating income$846.8M
Net income$552.5M
R&D
SG&A
D&A
SBC
Operating cash flow$354.0M
CapEx-$831.8M
Free cash flow-$137.8M
Total assets$7.79B
Total liabilities$4.62B
Total equity$3.17B
Cash & equivalents
Long-term debt$2.84B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.17B
Net cash-$2.84B
Current ratio1.3
Debt/Equity0.9
ROA7.1%
ROE17.4%
Cash conversion64.0%
CapEx/Revenue-7.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricINAMActivity
Op margin7.9%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin5.1%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin26.1%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-7.7%-7.1% medp25 -12.7% · p75 -4.4%below median
Debt / equity90.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:11 UTC#7521fbcc
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:13 UTCJob: b7f4f9ec